These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25677276)

  • 1. Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients.
    Pradhan ZS; Dalvi RA; Lai T; Kranemann C; Boyd S; Birt CM
    Can J Ophthalmol; 2015 Feb; 50(1):6-10. PubMed ID: 25677276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
    Reardon G; Schwartz GF; Mozaffari E
    Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
    Zhong Y; Shen X; Yu J; Tan H; Cheng Y
    Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study.
    Cellini M; Caramazza R; Bonsanto D; Bernabini B; Campos EC
    Ophthalmologica; 2004; 218(5):312-7. PubMed ID: 15334011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF; Tan J; Kotak S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
    Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
    Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
    Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
    Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
    Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
    Covert D; Robin AL
    Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monotherapy with lipid structural derivatives in glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2010; 54(2):30-43. PubMed ID: 20827909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
    Ulaş F; Balbaba M; Çelebi S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):658-62. PubMed ID: 23461283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Prostaglandin Analogues on the Ciliary Zonular Fibers of the Rabbit Crystalline Lens.
    Hwang HB; Kim SY
    Curr Eye Res; 2018 Nov; 43(11):1357-1361. PubMed ID: 30015523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis.
    Walt JG; Wilensky JT; Fiscella R; Chiang TH; Guckian A
    Clin Drug Investig; 2007; 27(12):819-25. PubMed ID: 18020539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostaglandin wars.
    Kaufman PL
    Am J Ophthalmol; 2003 Oct; 136(4):727-8. PubMed ID: 14516814
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
    Nixon DR
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.